cas 13796-49-1|| where to buy 2-[(1R,3aS,3bS,9aS,9bR,11aS)-9b-bromo-1,10-dihydroxy-2,9a,11a-trimethyl-7-oxo-1H,2H,3H,3aH,3bH,4H,5H,7H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-1-yl]-2-oxoethyl acetate

Название продукции:2-[(1R,3aS,3bS,9aS,9bR,11aS)-9b-bromo-1,10-dihydroxy-2,9a,11a-trimethyl-7-oxo-1H,2H,3H,3aH,3bH,4H,5H,7H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-1-yl]-2-oxoethyl acetate

IUPAC Name:2-[(1R,3aS,3bS,9aS,9bR,11aS)-9b-bromo-1,10-dihydroxy-2,9a,11a-trimethyl-7-oxo-1H,2H,3H,3aH,3bH,4H,5H,7H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-1-yl]-2-oxoethyl acetate

: CAS：13796-49-1; Молекулярная формула：C24H31BrO6; Чистота：95%+

: Номер в каталоге：CM1046906; Молекулярная масса：495.41

Упаковочная единица	Доступно для заказа	Цена ($)	Количество

Запрос: sales@chemenu.com

Только для использования в НИОКР..

Форма запроса

Химическое название

Номер CAS

Количество*

Необходимые спецификации*
(% пробы, категория материала и т.д.)

Контактное лицо*

Электронная почта*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 13796-49-1 regularly via the above email.

Дополнительные примечания

Verification code*

refresh

Информация о продукции

: Номер CAS:13796-49-1; Молекулярная формула:C24H31BrO6; Точка плавления:-; Smiles-код:CC1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3(C(C[C@@]2([C@]1(C(=O)COC(=O)C)O)C)O)Br)C; Плотность:

: Номер в каталоге:CM1046906; Молекулярная масса:495.41; Точка кипения:; Номер Mdl:; Хранение:

Column Infos

: Vamorolone; Dec 18, 2023, AGAMREE (vamorolone) has been approved in the European Union (EU) for the treatment of DMD in patients 4 years of age and older.
Duchenne muscular dystrophy (DMD) is a genetic muscle disease. And The feature is contraction-induced myofibre injury and inflammation. Researchers found that NF-κB signaling is active in dystrophin deficient muscle. Therefore, Inhibiting NF-κB is a potent strategy for the treatment of DMD. Vamorolone is an investigational drug that was developed as a novel dissociative steroidal anti-inflammatory. This means that its chemical profile is such that it shows chemical separation of efficacy (clinical benefit) from some safety concerns (side effect profiles) typically seen with corticosteroids.
AGAMREE is the only approved medication in the EU for treating DMD, and the first DMD treatment approved in both the U.S. and EU.

Форма запроса

Информация о продукции

Column Infos

Related Products